Researchers used single-nucleus RNA sequencing to study pancreatic ductal adenocarcinoma (PDAC) cachexia, revealing how tumors systematically break down skeletal muscle. Using a KPC mouse model, they discovered a unique “cachectic cluster” of muscle nuclei that activates protein-degrading genes while suppressing structural genes.
Not all muscle fibers were equally affected—fast-glycolytic Type IIb fibers suffered the most, while slow-oxidative Type I fibers were more resistant. Surprisingly, the muscle also ramped up protein synthesis through mTORC1 signaling, a protective response to counteract the massive protein loss. Disabling this pathway worsened muscle wasting, showing it is a natural rescue mechanism.
The study also found disruptions in the muscle microenvironment, including reduced blood vessel support and increased catabolic signals like TWEAK and myostatin. These findings suggest that future therapies should support the muscle’s own recovery mechanisms rather than just blocking protein breakdown, to better prevent the severe muscle loss that contributes to mortality in PDAC patients.